Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Psychopharmacology (Oxford, England)|June 30, 2010
Genetic moderation of CO2-induced fear by 5-HTTLPR genotypeKoen Schruers, Gabriel Esquivel, Marlies van Duinen, et al.
Brain : a Journal of Neurology|October 21, 2017
Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosisGourab Datta, Alessandro Colasanti, Eugenii A Rabiner, et al.
Journal of Psychopharmacology (Oxford, England)|January 7, 2021
Acute acetate administration increases endogenous opioid levels in the human brain: A [<sup>11</sup>C]carfentanil molecular imaging studyAbhishekh H Ashok, Jim Myers, Gary Frost, et al.
Neuroimage. Clinical|November 30, 2016
Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regionsCourtney A Bishop, Rexford D Newbould, Jean Sz Lee, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 29, 2014
In vivo imaging of cerebral dopamine D3 receptors in alcoholismDavid Erritzoe, Andri Tziortzi, David Bargiela, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 1, 2011
Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humansPaul Shotbolt, Andri C Tziortzi, Graham E Searle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2017
<sup>11</sup>C-PBR28 and <sup>18</sup>F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple SclerosisGourab Datta, Alessandro Colasanti, Nicola Kalk, et al.
Health Technology Assessment (Winchester, England)|May 12, 2025
Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trialJess Kerr-Gaffney, Zohra Zenasni, Kimberley Goldsmith, et al.
Molecular Psychiatry|June 27, 2018
Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individualsSamuel Turton, James Fm Myers, Inge Mick, et al.
The Lancet. Psychiatry|March 20, 2025
Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UKAnthony J Cleare, Jess Kerr-Gaffney, Kimberley Goldsmith, et al.
Pageof 6